- Big pharma -- investors are worried about President Obama's proposal to raise the rebates the companies would have to provide for popular drugs bought by Medicaid.
- Big biotech -- the fear is over the administration's roadmap for getting cheaper, generic versions of expensive, supposedly harder-to-reproduce biotech drugs on the market.
For more, read the article here.
Share this article with your social network, just click below to share now!
|
|
No comments :
Post a Comment